Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
Journal of Clinical Oncology, 2022 PURPOSE To provide recommendations for the management of patients with metastatic clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic literature review to obtain evidence to guide treatment recommendations. RESULTS The
W. Rathmell +16 more
semanticscholar +1 more source
Zhongliu Fangzhi Yanjiu, 2018 Objective To investigate the effect of long-chain non-coding RNA FILNC1 targeting c-Myc expression on the biological behavior of renal cell carcinoma. Methods qPCR was used to detect the expression of FILNC1 in renal cell carcinoma tissues and different ...
ZHANG Xiaofang, ZHAO Ying, LI Qi
doaj +1 more source
Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma. [PDF]
, 2018 Extensive genome-wide analyses of deregulated gene expression have now been performed for many types of cancer. However, most studies have focused on deregulation at the gene-level, which may overlook the alterations of specific transcripts for a given ...
Girke, Thomas +2 more
core +1 more source
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
European Urology, 2019 CONTEXT The European Association of Urology Renal Cell Carcinoma (RCC) Guideline Panel has prepared evidence-based guidelines and recommendations for the management of RCC. OBJECTIVE To provide an updated RCC guideline based on standardised methodology
B. Ljungberg +18 more
semanticscholar +1 more source
World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading in fine‐needle aspiration biopsies of renal masses [PDF]
, 2018 Background Utilization of fine‐needle aspiration (FNA) biopsy for the evaluation of renal masses has been increasing at our institution. At times diagnostic material on direct smears is superior to that in the cell block/core biopsy, therefore assigning
Al Nazer +20 more
core +1 more source
Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling [PDF]
, 2014 <b>Background:</b> Proteomics-based approaches for biomarker discovery are promising strategies used in cancer research. We present state-of-art label-free quantitative proteomics method to assess proteome of renal cell carcinoma (RCC ...
Atrih, A. +8 more
core +9 more sources
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study. [PDF]
PLoS ONE, 2013 Abnormal serum lipid profiles are associated with the risk of some cancers, but the direction and magnitude of the association with renal cell carcinoma is unclear.
Chunfang Zhang +8 more
doaj +1 more source
Renal cell carcinoma: a nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours [PDF]
, 2016 Aim To develop a nomogram from clinical and computed tomography (CT) data for pre-treatment identification of indolent renal cortical tumours. Patients and methods A total of 1201 consecutive patients underwent dedicated contrast-enhanced CT prior to ...
Asnis-Alibozek +15 more
core +1 more source
Epidemiology and Prevention of Renal Cell Carcinoma
Cancers, 2022 Simple Summary The incidence of renal cell carcinoma (RCC) rises globally with the highest rates in developed countries. This indicates not only the impact of advanced imaging, but also an increased prevalence of modifiable risk factors such as smoking ...
Tomoyuki Makino +3 more
semanticscholar +1 more source
Tumor Biology, 2017 Long non-coding RNAs have recently emerged as important regulators in the pathogenesis and progression of cancers. The long non-coding RNA urothelial carcinoma–associated 1 is reportedly upregulated and functions as an oncogene in some tumors.
Yun Lu +8 more
doaj +1 more source